GlassScriptPhysician profile
Erik V Berg
NPI 1235395500
$1,798.51
in general payments reported to CMS, 2019-2025
21 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.16 · 2020: $42.42 · 2021: $79.36 · 2022: $388 · 2023: $398 · 2024: $396 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,267.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $620.37 | 2021-2025 | Nucala |
| Genzyme Corporation | $347.98 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $215.70 | 2021-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $110.96 | 2025 | Tezspire, Tudorza Pressair |
| Medtronic, INC. | $65.83 | 2023-2025 | Propel |
| Abbvie INC. | $50.66 | 2022-2023 | Qulipta |
| Novartis Pharmaceuticals Corporation | $49.02 | 2022-2024 | |
| Genentech USA, INC. | $47.09 | 2023-2024 | Xolair |
| Ethicon US, LLC | $33.70 | 2024 | Vistaseal |
| Hikma Pharmaceuticals USA | $31.97 | 2023-2024 | Ryaltris |
| Stryker Corporation | $26.75 | 2022 | |
| Phadia US INC. | $25.27 | 2025 | Immunocap |
| Intersect Ent, INC. | $24.46 | 2020 | |
| Neurent Medical Limited | $23.10 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Lilly USA, LLC | $22.18 | 2025 | Zepbound |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $22.16 | 2019 | |
| Pfizer INC. | $20.32 | 2022 | |
| Smith+Nephew, INC. | $17.96 | 2020 | |
| Acclarent, INC | $16.53 | 2023 | Acclarent Aera |
| Merck Sharp & Dohme LLC | $14.43 | 2021 | |
| Aerin Medical INC. | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.